Moderna (MRNA) Shares Rally After Topping Q2 Estimates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Moderna COVID vaccine sales forecast unchanged even as COVAX program cuts orders
August 3, 2022 7:11 AM EDTBy Michael Erman and Manas Mishra
(Reuters) - Moderna Inc on Wednesday maintained its full-year COVID-19 vaccine sales forecast of $21 billion as canceled orders from low- and middle-income nations through the COVAX program offset gains from new booster dose orders.
Moderna shares jumped nearly 17% in morning trading after the company also announced a $3 billion share buyback plan.
Moderna has begun producing a redesigned booster shot targeting both the original coronavirus as well as the BA.4 and BA.5 Omicron subvariants.
It signed a $1.74 billion deal with the U.S. government... More
Moderna (MRNA) announces new $3 billion share repurchase plan
August 3, 2022 7:11 AM EDTWith earnings, Moderna (NASDAQ: MRNA) announces a new $3 billion share repurchase plan.
Moderna (MRNA) Tops Q2 EPS by 70c, Beats on Revenue
August 3, 2022 7:02 AM EDTModerna (NASDAQ: MRNA) reported Q2 EPS of $5.24, $0.70 better than the analyst estimate of $4.54. Revenue for the quarter came in at $4.7 billion versus the consensus estimate of $4.07 billion.
For earnings history and earnings-related data on Moderna (MRNA) click here.
... MoreModerna (MRNA) August weekly 160 straddle priced for a move of 8% into quarter results
August 3, 2022 4:02 AM EDTModerna (NASDAQ: MRNA) August weekly 160 straddle priced for a move of 8% into the expected release of quarter results today after the bell.
... MoreModerna (MRNA) call put ratio 2.6 calls to 1 put into quarter results and outlook
August 2, 2022 10:30 AM EDTModerna (NASDAQ: MRNA) August weekly call option implied volatility is at 104, August is at 70; compared to its 52-week range of 58 to 97 into the expected release of quarter results after the bell on August 3.
... MoreModerna (MRNA) August weekly 160 straddle priced for a move of 8% into quarter
August 2, 2022 6:16 AM EDTModerna (NASDAQ: MRNA) August weekly 160 straddle priced for a move of 8% into the expected release of quarter results after the bell on August 3.
... MoreJPMorgan Assumes Moderna (MRNA) at Neutral
August 1, 2022 5:03 PM EDTJPMorgan analyst Jessica Fye assumes coverage on Moderna (NASDAQ: MRNA) with a Neutral rating and a price target of $165.00.
For an analyst ratings summary and ratings history on Moderna click here. For more ratings news on Moderna click here.
Shares of Moderna closed at $164.09 yesterday.
... More